SCOR reaffirms its independence and acknowledges Covéa’s decision to withdraw its proposal on a potential combination
- FR
- EN
SCOR reaffirms its independence and acknowledges Covéa’s decision to withdraw its proposal on a potential combination
SCOR Global Life continues to promote health and wellness initiatives through a new partnership with Human Longevity, Inc.
Disclosure of transactions in own shares from August 20 to August 24, 2018
Disclosure of transactions in own shares from August 13 to August 17, 2018
Disclosure of transactions in own shares from August 6 to August 10, 2018
Disclosure of transactions in own shares from July 30 to August 3, 2018
Disclosure of transactions in own shares from July 23 to July 27, 2018
Viral hepatitis is currently the world’s 7th deadliest human disease. To mark World Hepatitis Day on June 28, SCOR Global Life Medical Director Dr.
SCOR announces the public release and the filing with the Autorité des marchés financiers of its interim financial report for the six months ended June 30, 2018.
Half-year 2018 results
Pagination